This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Manfred Roesner: Innovator in Cancer Treatment
Introduction
Manfred Roesner is a notable inventor based in Eppstein/Bremthal, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Roesner holds a patent for "Substituted benzimidazole compounds and their use for the treatment of cancer." This invention discloses and claims benzimidazole compounds of a specific formula, which are designed to be effective in treating cancer. The patent details various chemical structures and their potential applications in pharmaceutical compositions, emphasizing the importance of these compounds in modern medicine.
Career Highlights
Manfred Roesner is associated with Aventis Pharma S.A., a prominent company in the pharmaceutical industry. His work at Aventis has allowed him to focus on innovative research and development, contributing to the advancement of cancer therapies. His dedication to improving patient outcomes through scientific research is evident in his patent and ongoing projects.
Collaborations
Throughout his career, Roesner has collaborated with esteemed colleagues such as Isabelle Depaty and Odile Angouillant-Boniface. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Manfred Roesner's contributions to cancer treatment through his patented inventions highlight his role as a key innovator in the pharmaceutical industry. His work continues to inspire advancements in medical research and development.